PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,110.00
Bid: 12,086.00
Ask: 12,088.00
Change: -56.00 (-0.46%)
Spread: 2.00 (0.017%)
Open: 12,186.00
High: 12,198.00
Low: 12,068.00
Prev. Close: 12,166.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 4-British grandma is 1st in world to get Pfizer vaccine outside trial

Tue, 08th Dec 2020 07:09

* 90-year-old grandmother gets Pfizer vaccine

* Britain rolls out COVID vaccine, first in the West

* 'I feel so privileged' says first vaccine recipient
(Adds background)

By Kate Holton

LONDON, Dec 8 (Reuters) - Margaret Keenan, a 90-year-old
grandmother from Northern Ireland, became the first person in
the world on Tuesday to receive the Pfizer COVID-19
vaccine shot outside of a trial as Britain began vaccinating its
population.

An early riser, Keenan received the Pfizer-BioNTech vaccine
at her local hospital in Coventry, central England, on Tuesday
morning at 0631 GMT, a week before she turns 91.

A video showed Keenan being pushed in a wheelchair out of
the ward while nursing staff clad in protective gear lined the
corridor to applaud and cheer, in an echo of moving video clips
released through the year when COVID-19 survivors finally left
hospital.

Britain is the first Western country to start immunising its
general population in what has been hailed as a decisive
watershed in defeating the coronavirus.

"I feel so privileged to be the first person vaccinated
against COVID-19," said Keenan, as she received the shot from a
nurse originally from the Philippines in front of a photographer
and TV crew.

"It's the best early birthday present I could wish for
because it means I can finally look forward to spending time
with my family and friends in the New Year after being on my own
for most of the year."

Keenan, known as Maggie to her friends, is a former
jewellery shop assistant who only retired four years ago. She
has a daughter, a son and four grandchildren.

Video footage showed her wearing a light blue mask, a grey
cardigan along with a blue t-shirt with a penguin in snow and
the message "Merry Christmas" as she received the shot in her
left arm from nurse May Parsons.

"WE WILL BEAT THIS TOGETHER"

Parsons, one of many thousands of people from around the
world employed in Britain's National Health Service (NHS), where
she has worked for 24 years, said the last few months had been
tough, but there was now light at the end of the tunnel.

Britain is the worst-hit European country from COVID-19,
with over 61,000 deaths. Prime Minister Boris Johnson hopes to
turn the tide against the disease by rolling out the
Pfizer/BioNTech vaccine before the United States or European
Union.

The mass inoculation will fuel hope the world may be turning
a corner in the fight against a pandemic that has crushed
economies and killed more than 1.5 million, although ultra-cold
storage and tricky logistics will limit its use for now.

"Thank you to our NHS, to all of the scientists who worked
so hard to develop this vaccine, to all the volunteers - and to
everyone who has been following the rules to protect others,"
Johnson said on Twitter.

"We will beat this together."

British Health Secretary Matt Hancock and Stephen Powis,
medical director for NHS England, said they both found it very
emotional watching the vaccine programme rollout.

The BBC said the second patient to receive the jab in
Britain was a man named William Shakespeare from Warwickshire.

Britain has ordered 40 million doses of the Pfizer/BioNTech
shot. As each person requires two doses, that is enough to
vaccinate 20 million people in the country of 67 million.

About 800,000 doses are expected to be available within the
first week, with care home residents and carers, the over-80s
and some health service workers the top priority to get them.
(Editing by Estelle Shirbon, Guy Faulconbridge and Gareth
Jones)

More News
2 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 buoyed by UK manufacturing growth

(Alliance News) - The FTSE 100 in London was up at midday on Tuesday, reacting to the UK manufacturing sector returning growth and further PMI data across the globe.

Read more
2 Apr 2024 10:25

AstraZeneca and Daiichi make US progress with latest licence approvals

(Alliance News) - AstraZeneca PLC on Tuesday noted significant progress for two of its clinical-stage treatments in the US.

Read more
2 Apr 2024 09:54

LONDON BROKER RATINGS: Bernstein starts AstraZeneca at 'outperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
2 Apr 2024 09:09

LONDON MARKET OPEN: FTSE 100 up as oil majors and gold miners shine

(Alliance News) - Stock prices in London opened higher on Tuesday, in confident trade following the long Easter weekend, ahead of a UK manufacturing sector reading later in the morning.

Read more
2 Apr 2024 08:05

LONDON BRIEFING: HSBC in special payout on Canada sale; Astra FDA win

(Alliance News) - London's FTSE 100 traded higher on Tuesday following the long weekend, as investors react to US data, and look ahead to manufacturing sector readings from Europe later.

Read more
2 Apr 2024 07:08

US FDA gives green light for use of AstraZeneca's Voydeva

(Sharecast News) - America's drug regulator gave the green light to AstraZeneca's for the add-on use of Voydeya in the treatment of extravascular haemolysis (EVH) in patients with paroxysmal nocturnal haemoglobinuria (PNH).

Read more
27 Mar 2024 12:02

LONDON MARKET MIDDAY: FTSE 100 underperforms ahead of US PCE data

(Alliance News) - Stock prices in London were lower at midday on Wednesday, but trade was more confident in mainland Europe, with focus turning to the release of the US Federal Reserve's preferred inflation gauge on Friday.

Read more
27 Mar 2024 11:56

C4X Discovery seeks AIM delisting but half-year revenue skyrockets

(Alliance News) - C4X Discovery Holdings PLC shares plunged on Wednesday after it said it plans to delist from AIM in London, due to "the recent downturn in the financial markets" hampering its valuation.

Read more
27 Mar 2024 09:19

AstraZeneca treatments become "first and only" to be approved in Japan

(Alliance News) - AstraZeneca PLC announced on Wednesday the approval of two of its treatments for use in Japan.

Read more
27 Mar 2024 09:03

LONDON MARKET OPEN: FTSE 100 slips as unease lingers before US data

(Alliance News) - Stock prices in London edged lower after the open on Wednesday, with some nervy trade ahead of a US inflation reading later in the week.

Read more
27 Mar 2024 08:02

LONDON BRIEFING: Diploma makes buy; Astra wins Japan drug approvals

(Alliance News) - Stocks in London opened in a muted fashion on Wednesday, with some unease lingering in equity markets ahead of a US inflation reading later in the week.

Read more
26 Mar 2024 10:18

China to speed up 'new productive forces', vice president says

BEIJING, March 26 (Reuters) - China will accelerate the development of "new productive forces" and bolster stability and security for the global economy, Vice President Han Zheng told an investment forum in Beijing, as the world's no.2 economy seeks to reassure anxious foreign firms.

Read more
25 Mar 2024 12:09

LONDON MARKET MIDDAY: Stocks make tepid start to new week

(Alliance News) - Stock prices in London were down at midday on Monday, giving back some gains from last week, when equities were boosted by central bank decisions and accompanying statements which investors saw as dovish.

Read more
25 Mar 2024 09:04

LONDON MARKET OPEN: FTSE 100 treads water, FTSE 250 declines

(Alliance News) - The FTSE 100 in London traded flat early Monday, while the pound remained below the USD1.26 mark, as Bank of England Governor Andrew Bailey suggested rate cuts may happen soon.

Read more
25 Mar 2024 08:40

TOP NEWS: AstraZeneca wins US approval for rare nervous system disease

(Alliance News) - AstraZeneca PLC on Monday said its Ultomiris treatment has been approved by the US Food & Drug Administration as the first and only long-acting C5 complement inhibitor to treat neuromyelitis optica spectrum disorder in adults.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.